Literature DB >> 15374854

Accelerated atherosclerosis in patients with Wegener's granulomatosis.

K de Leeuw1, J-S Sanders, C Stegeman, A Smit, C G Kallenberg, M Bijl.   

Abstract

BACKGROUND: Several autoimmune disorders are complicated by excess cardiovascular disease. In addition to traditional risk factors, non-traditional risk factors such as endothelial activation and excessive vascular remodelling might be determinants of the progression of atherosclerosis in patients with an autoimmune disease.
OBJECTIVE: To evaluate whether patients with Wegener's granulomatosis (WG) have an increased prevalence of atherosclerosis and to determine predisposing factors.
METHODS: 29 WG patients (19 men; mean (SD) age, 53 (14) years) with inactive disease and 26 controls (16 men; age 53 (15) years) were studied. Common carotid intima-media thickness (IMT) was measured by ultrasound. In all individuals traditional risk factors for cardiovascular disease were determined. High sensitivity C reactive protein (hsCRP) was measured. Endothelial activation was assessed by measuring thrombomodulin, vascular cell adhesion molecule-1, and von Willebrand factor. As a marker of vascular remodelling matrix metalloproteinases (MMP-3 and MMP-9) and TIMP-1 were measured.
RESULTS: IMT was increased in WG patients compared with controls (p<0.05). No differences in traditional risk factors and endothelial activation markers between patients and controls were found. Levels of hsCRP, MMPs, and TIMP-1 were increased in WG patients (p<0.05).
CONCLUSIONS: Increased IMT found in WG patients cannot be explained by an increased prevalence of traditional risk factors. Although endothelial activation markers in WG patients with inactive disease were not increased, the raised levels of hsCRP, MMPs, and TIMP-1 suggest that enhanced inflammation and excessive vascular remodelling are contributing factors in the development of accelerated atherosclerosis in WG.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374854      PMCID: PMC1755479          DOI: 10.1136/ard.2004.029033

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  40 in total

1.  Does B-mode common carotid artery intima-media thickness differ from M-model?

Authors:  L M Van Bortel; F H Vanmolkot; J J van der Heijden-Spek; M Bregu; J A Staessen; A P Hoeks
Journal:  Ultrasound Med Biol       Date:  2001-10       Impact factor: 2.998

2.  Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Authors:  J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal
Journal:  Arthritis Rheum       Date:  2001-10

3.  Circulating soluble adhesion molecules in ANCA-associated vasculitis.

Authors:  J Ara; E Mirapeix; P Arrizabalaga; R Rodriguez; C Ascaso; R Abellana; J Font; A Darnell
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

4.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography.

Authors:  Kerrie L Faia; Wendell P Davis; Adele J Marone; Thomas L Foxall
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

5.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

6.  Direct proinflammatory effect of C-reactive protein on human endothelial cells.

Authors:  V Pasceri; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

7.  Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.

Authors:  M D Posthumus; P C Limburg; J Westra; M A van Leeuwen; M H van Rijswijk
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

8.  In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis.

Authors:  A C Muller Kobold; R T van Wijk; C F Franssen; G Molema; C G Kallenberg; J W Tervaert
Journal:  Clin Exp Rheumatol       Date:  1999 Jul-Aug       Impact factor: 4.473

9.  Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease.

Authors:  Carlos Gonzalez-Juanatey; Javier Llorca; Ana Testa; Javier Revuelta; Carlos Garcia-Porrua; Miguel A Gonzalez-Gay
Journal:  Medicine (Baltimore)       Date:  2003-11       Impact factor: 1.889

10.  Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation.

Authors:  A D Booth; S Wallace; C M McEniery; J Brown; D R W Jayne; I B Wilkinson
Journal:  Arthritis Rheum       Date:  2004-02
View more
  45 in total

1.  Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Paul A Monach; Gunnar Tomasson; Ulrich Specks; John H Stone; David Cuthbertson; Jeffrey Krischer; Linna Ding; Fernando C Fervenza; Barri J Fessler; Gary S Hoffman; David Ikle; Cees G M Kallenberg; Carol A Langford; Mark Mueller; Philip Seo; E William St Clair; Robert Spiera; Nadia Tchao; Steven R Ytterberg; Yi-Zhong Gu; Ronald D Snyder; Peter A Merkel
Journal:  Arthritis Rheum       Date:  2011-12

2.  HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients.

Authors:  Wijtske Annema; Arne Dikkers; Jan Freark de Boer; Robin P F Dullaart; Jan-Stephan F Sanders; Stephan J L Bakker; Uwe J F Tietge
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis.

Authors:  G Chironi; C Pagnoux; A Simon; M Pasquinelli-Balice; M Del-Pino; J Gariepy; L Guillevin
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

4.  Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome.

Authors:  Satish M Rachapalli; Patrick D Kiely; Brian E Bourke
Journal:  Clin Rheumatol       Date:  2009-02-10       Impact factor: 2.980

5.  Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

Authors:  K Raza; D M Carruthers; R Stevens; A D Filer; J N Townend; P A Bacon
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

Review 6.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

7.  Arterial distensibility in chronic inflammatory rheumatic disorders.

Authors:  Mustafa Yildiz
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

8.  Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

9.  Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare.

Authors:  Emmanuel Ribeiro; Thomas Cressend; Pierre Duffau; Marieke Grenouillet-Delacre; Marie Rouanet-Larivière; Anne Vital; Maïté Longy-Boursier; Patrick Mercié
Journal:  Case Rep Med       Date:  2010-03-14

10.  Genetic variability of RXRB, PPARA, and PPARG in Wegener's granulomatosis.

Authors:  Stefan Wieczorek; Silvia Knaup; Wolfgang L Gross; Jörg T Epplen
Journal:  PPAR Res       Date:  2009-02-11       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.